Keyword: bioequivalent

From Brands to Generics - No Monopoly, No Competition (7/31/2002)

By providing incentives for brand-name drug companies to fund expensive R&D, temporary patents for expensive blockbuster drugs inadvertently lead to cheaper generic rivals when the patents expire.